NLS Pharmaceutics AG Statistics
Total Valuation
NLSP has a market cap or net worth of $8.41 million. The enterprise value is $9.14 million.
| Market Cap | 8.41M |
| Enterprise Value | 9.14M |
Important Dates
The next estimated earnings date is Tuesday, July 16, 2024, after market close.
| Earnings Date | Jul 16, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NLSP has 42.03 million shares outstanding. The number of shares has increased by 220.76% in one year.
| Shares Outstanding | 42.03M |
| Shares Change (YoY) | +220.76% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 31.54% |
| Owned by Institutions (%) | 29.72% |
| Float | 19.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.23
| Current Ratio | 0.23 |
| Quick Ratio | n/a |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -82.86 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -218.90% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.03M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.33% in the last 52 weeks. The beta is -0.68, so NLSP's price volatility has been lower than the market average.
| Beta (5Y) | -0.68 |
| 52-Week Price Change | -83.33% |
| 50-Day Moving Average | 0.15 |
| 200-Day Moving Average | 0.40 |
| Relative Strength Index (RSI) | 55.13 |
| Average Volume (20 Days) | 28,708,712 |
Short Selling Information
The latest short interest is 212,339, so 0.51% of the outstanding shares have been sold short.
| Short Interest | 212,339 |
| Short Previous Month | 375,183 |
| Short % of Shares Out | 0.51% |
| Short % of Float | 1.08% |
| Short Ratio (days to cover) | 0.16 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.81M |
| Pretax Income | -12.17M |
| Net Income | -12.17M |
| EBITDA | -12.02M |
| EBIT | -12.03M |
| Earnings Per Share (EPS) | -$0.32 |
Balance Sheet
The company has $897,680 in cash and $1.63 million in debt, giving a net cash position of -$736,066 or -$0.02 per share.
| Cash & Cash Equivalents | 897,680 |
| Total Debt | 1.63M |
| Net Cash | -736,066 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | -8.83M |
| Book Value Per Share | -0.21 |
| Working Capital | -6.10M |
Cash Flow
| Operating Cash Flow | -9.68M |
| Capital Expenditures | n/a |
| Free Cash Flow | -9.68M |
| FCF Per Share | -$0.25 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
NLSP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -220.76% |
| Shareholder Yield | -220.76% |
| Earnings Yield | -144.81% |
| FCF Yield | -115.21% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |